Pick's disease management: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 14: Line 14:
}}
}}
{{SI}}
{{SI}}
{{EH}}
{{CMG}}


==Overview==
==Overview==
Line 71: Line 71:
*[[Corticobasal degeneration]]
*[[Corticobasal degeneration]]


==External links==
{{SIB}}
*[http://health.groups.yahoo.com/group/FTD_support/ Fronto-temporal dementia online support group]
*[http://health.groups.yahoo.com/group/picks-support/ Pick's dementia online support group]
*[http://www.ftd-picks.org/ The Association for Frontotemporal Dementias]
*[http://memory.ucsf.edu UCSF Memory and Aging Center] - [http://memory.ucsf.edu/resources.html#ftd FTD Resources] and [http://memory.ucsf.edu/Education/Disease/ftd.html FTD Info]
*Mayo Clinic - [http://www.mayoclinic.com/invoke.cfm?id=AN00541 FTD Info]
*[http://www.pdsg.org.uk/ Pick's Disease Support Group Online]
*[http://www.ftdsupport.com/ Frontotemporal Dementia Caregiver Support Center]


{{SIB}}
[[Category:Disease state]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Psychiatry]]
[[Category:Cognitive disorders]]
[[Category:Cognitive disorders]]



Revision as of 14:56, 7 August 2011

Pick's disease management
A human brain showing frontotemporal lobar degeneration causing frontotemporal dementia.
ICD-9 331.19
OMIM 600274
DiseasesDB 10034
MeSH D003704

WikiDoc Resources for Pick's disease management

Articles

Most recent articles on Pick's disease management

Most cited articles on Pick's disease management

Review articles on Pick's disease management

Articles on Pick's disease management in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pick's disease management

Images of Pick's disease management

Photos of Pick's disease management

Podcasts & MP3s on Pick's disease management

Videos on Pick's disease management

Evidence Based Medicine

Cochrane Collaboration on Pick's disease management

Bandolier on Pick's disease management

TRIP on Pick's disease management

Clinical Trials

Ongoing Trials on Pick's disease management at Clinical Trials.gov

Trial results on Pick's disease management

Clinical Trials on Pick's disease management at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pick's disease management

NICE Guidance on Pick's disease management

NHS PRODIGY Guidance

FDA on Pick's disease management

CDC on Pick's disease management

Books

Books on Pick's disease management

News

Pick's disease management in the news

Be alerted to news on Pick's disease management

News trends on Pick's disease management

Commentary

Blogs on Pick's disease management

Definitions

Definitions of Pick's disease management

Patient Resources / Community

Patient resources on Pick's disease management

Discussion groups on Pick's disease management

Patient Handouts on Pick's disease management

Directions to Hospitals Treating Pick's disease management

Risk calculators and risk factors for Pick's disease management

Healthcare Provider Resources

Symptoms of Pick's disease management

Causes & Risk Factors for Pick's disease management

Diagnostic studies for Pick's disease management

Treatment of Pick's disease management

Continuing Medical Education (CME)

CME Programs on Pick's disease management

International

Pick's disease management en Espanol

Pick's disease management en Francais

Business

Pick's disease management in the Marketplace

Patents on Pick's disease management

Experimental / Informatics

List of terms related to Pick's disease management

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Frontotemporal dementia (FTD) is a clinical syndrome caused by degeneration of the frontal lobe of the brain and may extend back to the temporal lobe. It is one of three syndromes caused by frontotemporal lobar degeneration.

Symptoms can be classified (roughly) into two groups which underlie the functions of the frontal lobe: behavioural symptoms (and/or personality change) and symptoms related to problems with executive function.

Behavioural symptoms include apathy and aspontaneity or oppositely disinhibition. Apathetic patients may become socially withdrawn and stay in bed all day or no longer take care of themselves. Disinhibited patients can make inappropriate (sometimes sexual) comments or perform inappropriate acts. Patients with FTD can sometimes get into trouble with the police because of inappropriate behaviour such as stealing.

Executive function is the cognitive skill of planning and organizing - patients become unable to perform skills that require complex planning or sequencing.

FTD can occur in patients with motor neuron disease (also known in the US as Lou Gehrig's disease or amyotrophic lateral sclerosis) in a small number of cases. The prognosis for people with MND is worse when combined with FTD, shortening survival by about a year.[2]

Because FTD often occurs in younger people (i.e. in their 40's or 50's), it can severely effect families. Patients often still have children living in the home. Financially, it can be devastating as the disease strikes at the time of life that are often the top wage earning years.

Pathology

A number of case series have now been published looking at the pathological basis of frontotemporal dementia. As with other syndromes associated with FTLD, a number of different pathologies are associated with FTD:

  • Pick's disease (3-repeat Tau inclusions)
  • Other tau-positive pathology including FTDP-17, corticobasal degeneration, progressive supranuclear palsy
  • FTLD with ubiquitin positive, tau- and alpha-synuclein negative inclusions with and without motor neuron degeneration (recently characterized by nuclear and cytoplasmic staining of TDP-43 protein)
  • Dementia lacking distinctive histology
  • In rare cases, patients with clinical FTD were found to have changes consistent with Alzheimer's disease on autopsy
  • Evidence suggests that FTD selectively impairs spindle neurons, a type of neuron which has only been found in the brains of humans, great apes, and whales

Imaging

Structural MRI scans often reveal frontal lobe and/or temporal lobe atrophy but in early cases the scan may seem normal. Atrophy may be asymmetric. Registration of images at different time points (e.g. one year apart) can show evidence of atrophy in two cross-sectional images that may be reported as normal. This is a useful diagnostic technique. However, many research groups are currently looking at ways of making an early diagnosis of FTD using other techniques (magnetic resonance spectroscopy, functional imaging, cortical thickness measurements etc.). FDG-PET scans classically show frontal hypometabolism, which helps differentiate from Alzheimer's disease. The PET scan in Alzheimer's disease classically shows biparietal hypometabolism.

Genetics

A higher proportion of FTD cases seem to have a familial component (perhaps more so than Alzheimer's disease). Two known mutations are associated with familial FTD: tau-positive frontotemporal dementia with parkinsonism (FTDP-17) with mutations in the MAPT gene on chromosome 17, and tau-negative frontotemporal lobar degeneration with ubiquintin-positive inclusions (FTLD-U; positive for TDP-43)with progranulin mutations (also on chromosome 17). However, it is estimated that each of these two genes only accounts for about 5-10% of all cases of FTD, thus other genes or heritable components are likely responsible for the high degree of heritability in FTD.

Management

There is no known curative treatment for FTD. Supportive care is essential. Management of behavioural symptoms may be necessary (e.g. SSRIs for depression; atypical neuroleptics etc.).

Further reading

References

  • Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF. "Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria." 'Neurology' (1998) 51(6):1546-54. Available: [3]
  • Neary D, Snowden JS, Mann DM. "Classification and description of frontotemporal dementias." Ann N Y Acad Sci (2000) 920:46-51. Available: [4]
  • Kramer JH, Jurik J, Sha SJ, Rankin KP, Rosen HJ, Johnson JK, Miller BL. "Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease." Cogn Behav Neurol. (2003) 16(4):211-8. Available: [5]
  • Rosen HJ, Gorno-Tempini ML, Goldman WP, Perry RJ, Schuff N, Weiner M, Feiwell R, Kramer JH, Miller BL. "Patterns of brain atrophy in frontotemporal dementia and semantic dementia." Neurology (2002) 58(2):198-208. Available: [6]
  • Miller BL, Seeley WW, Mychack P, Rosen HJ, Mena I, Boone K. "Neuroanatomy of the self: Evidence from patients with frontotemporal dementia." Neurology (2001) 57:817-821. Available: [7]
  • Diehl J, Ernst J, Krapp S, Forstl H, Nedopil N, Kurz A. (2006) [Misdemeanor in frontotemporal dementia] Fortschr Neurol Psychiatr. 74(4):203-10. [PMID 16671160]
  • Seeley WW, Carlin DA, Allman JM, Macedo MN, Bush C, Miller BL, Dearmond SJ. (2006) Early frontotemporal dementia targets neurons unique to apes and humans. Ann Neurology.

See also

Template:SIB

de:Frontotemporale Demenz nl:Frontotemporale dementie sv:Frontallobsdegeneration av icke-Alzheimer Template:WH Template:WS